Items where the Publication is Journal of hepatology
Number of items: 15.
2018
A measure of alcohol consumption in late adolescence associated with liver disease after 39 years of follow-up is insufficient to guide alcohol safe limits. (2018)
Askgaard, G; Tolstrup, JS; Leon, DA
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa. (2018)
Shimakawa, Yusuke; Njie, Ramou; Ndow, Gibril; Vray, Muriel; Mbaye, Papa Saliou; Bonnard, Philippe; Sombié, Roger; Nana, Jean; Leroy, Vincent; Bottero, Julie; Ingiliz, Patrick; Post, Gerrit; Sanneh, Bakary; Baldeh, Ignatius; Suso, Penda; Ceesay, Amie; Jeng, Adam; Njai, Harr Freeya; Nayagam, Shevanthi; D'Alessandro, Umberto; Chemin, Isabelle; Mendy, Maimuna; Thursz, Mark; Lemoine, Maud
2017
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease. (2017)
Hedegaard, Ditte L; Tully, Damien C; Rowe, Ian A; Reynolds, Gary M; Bean, David J; Hu, Ke; Davis, Christopher; Wilhelm, Annika; Ogilvie, Colin B; Power, Karen A; Tarr, Alexander W; Kelly, Deirdre; Allen, Todd M; Balfe, Peter; McKeating, Jane A
2016
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation. (2016)
Martin, Natasha K; Vickerman, Peter; Dore, Gregory J; Grebely, Jason; Miners, Alec; Cairns, John; Foster, Graham R; Hutchinson, Sharon J; Goldberg, David J; Martin, Thomas CS; Ramsay, Mary; STOP-HCV Consortium; Hickman, Matthew
2013
COST-EFFECTIVENESS OF INCREASING HCV CASE-FINDING FOR PEOPLE WHO INJECT DRUGS VIA DRIED BLOOD SPOT TESTING IN ADDICTION SERVICES AND PRISONS. (2013)
Martin, NK; Hickman, M; Miners, A; Hutchinson, SJ; Taylor, A; Vickerman, P
ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS. (2013)
Martin, NK; Vickerman, P; Clements, A; Cramp, M; de Angeles, D; Dillon, JF; Fahey, S; Foster, GR; Goldberg, DJ; Gordon, F; Hutchinson, SJ; Irving, W; Lewis, H; Ryder, S; Ustainowski, A; Vilar, J; Hickman, M
COMMUNITY-BASED SCREENING FOR HEPATITIS B VIRUS INFECTION IN THE GAMBIA, WEST AFRICA: PREVALENCE OF INFECTION AND FACTORS AFFECTING THE SCREENING ATTENDANCE. (2013)
Shimakawa, Y; Lemoine, M; Njai, HF; Jatta, A; Sanneh, B; Taal, M; Corrah, T; D'Alessandro, U; Njie, R; Thursz, M
Reduction of HBV replication prolongs the early immunological response to IFNα therapy. (2013)
Tan, Anthony T; Hoang, Long Truong; Chin, Daniel; Rasmussen, Erik; Lopatin, Uri; Hart, Stefan; Bitter, Hans; Chu, Tom; Gruenbaum, Lore; Ravindran, Palani; Zhong, Hua; Gane, Ed; Lim, Seng Gee; Chow, Wan Cheng; Chen, Pei-Jer; Petric, Rosemary; Bertoletti, Antonio; Hibberd, Martin Lloyd
2011
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. (2011)
Martin, Natasha K; Vickerman, Peter; Foster, Graham R; Hutchinson, Sharon J; Goldberg, David J; Hickman, Matthew
PNPLA3 SEQUENCE VARIANT (RS738409) CONFERS SUSCEPTIBILITY TO LIVER DAMAGE AND CIRRHOSIS IN HCV RELATED LIVER DISEASE. (2011)
Thursz, M; Corradini, SG; Toniutto, P; Molinaro, A; Palla, L; Knapp, S; Anstee, Q; Huang-Doran, I; Goldin, R; Romeo, S